U.S. Files Consent Decree for Permanent Injunction Against Pharmaceutical Ranbaxy Laboratories

The United States has filed a consent decree for permanent injunction against the generic drug manufacturer Ranbaxy Laboratories Ltd., an Indian corporation, in the U.S. District Court for the District of Maryland, the Department of Justice announced today.